IL121017A0 - Method of screening compounds for LC132 receptor agonist - Google Patents
Method of screening compounds for LC132 receptor agonistInfo
- Publication number
- IL121017A0 IL121017A0 IL12101797A IL12101797A IL121017A0 IL 121017 A0 IL121017 A0 IL 121017A0 IL 12101797 A IL12101797 A IL 12101797A IL 12101797 A IL12101797 A IL 12101797A IL 121017 A0 IL121017 A0 IL 121017A0
- Authority
- IL
- Israel
- Prior art keywords
- receptor agonist
- screening compounds
- screening
- compounds
- agonist
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9486—Analgesics, e.g. opiates, aspirine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96109462 | 1996-06-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL121017A0 true IL121017A0 (en) | 1997-11-20 |
Family
ID=8222893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12101797A IL121017A0 (en) | 1996-06-13 | 1997-06-06 | Method of screening compounds for LC132 receptor agonist |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6326156B1 (xx) |
| JP (1) | JP3212537B2 (xx) |
| KR (1) | KR100247670B1 (xx) |
| CN (1) | CN1184254A (xx) |
| AR (1) | AR007548A1 (xx) |
| AU (1) | AU719519B2 (xx) |
| BR (1) | BR9703546A (xx) |
| CA (1) | CA2206192A1 (xx) |
| CZ (1) | CZ179597A3 (xx) |
| HU (1) | HUP9701032A3 (xx) |
| IL (1) | IL121017A0 (xx) |
| MX (1) | MX9704352A (xx) |
| NO (1) | NO972707L (xx) |
| NZ (1) | NZ328033A (xx) |
| PL (1) | PL320527A1 (xx) |
| TR (1) | TR199700482A2 (xx) |
| ZA (1) | ZA975077B (xx) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA80841C2 (en) * | 2002-10-07 | 2007-11-12 | Univ California | Fatty acid amide hydrolase inhibitors, pharmaceutical composition (variants) and method to treat appetite disorders, glaucoma, pain, and related neurological disorders (variants) |
| WO2008030752A2 (en) * | 2006-09-07 | 2008-03-13 | N.V. Organon | Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo |
| JO3598B1 (ar) | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
| WO2008063714A1 (en) * | 2006-11-20 | 2008-05-29 | N.V. Organon | Metabolically-stabilized inhibitors of fatty acid amide hydrolase |
| WO2009126691A1 (en) | 2008-04-09 | 2009-10-15 | Infinity Pharmaceuticals, Inc | Inhibitors of fatty acid amide hydrolase |
| CA2757622A1 (en) | 2009-04-07 | 2010-10-14 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
| EP2416660B1 (en) | 2009-04-07 | 2014-07-02 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
| US8765735B2 (en) * | 2009-05-18 | 2014-07-01 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
| US8927551B2 (en) * | 2009-05-18 | 2015-01-06 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
| US9149465B2 (en) * | 2009-05-18 | 2015-10-06 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
| CA2788587C (en) | 2010-02-03 | 2020-03-10 | Infinity Pharmaceuticals, Inc. | Fatty acid amide hydrolase inhibitors |
| RU2583435C2 (ru) | 2010-07-28 | 2016-05-10 | Те Риджентс Оф Те Юниверсити Оф Калифорния | Ингибиторы faah периферически-ограниченного действия |
| AU2012299060B2 (en) | 2011-08-19 | 2017-06-01 | Fondazione Istituto Italiano Di Tecnologia | Meta-substituted biphenyl peripherally restricted FAAH inhibitors |
| WO2013049332A1 (en) | 2011-09-29 | 2013-04-04 | Infinity Pharmaceuticals, Inc. | Inhibitors of monoacylglycerol lipase and methods of their use |
| WO2015157313A1 (en) | 2014-04-07 | 2015-10-15 | The Regents Of The University Of California | Inhibitors of fatty acid amide hydrolase (faah) enzyme with improved oral bioavailability and their use as medicaments |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5316759A (en) * | 1986-03-17 | 1994-05-31 | Robert J. Schaap | Agonist-antagonist combination to reduce the use of nicotine and other drugs |
| DE3718317A1 (de) | 1986-12-10 | 1988-06-16 | Bayer Ag | Substituierte basische 2-aminotetraline |
| EP0612845A3 (en) | 1993-02-26 | 1994-09-21 | American Cyanamid Co | Purified opioid receptor. |
| US6096513A (en) | 1993-05-20 | 2000-08-01 | Arch Development Corporation | Polynucleotides encoding KAPPA opiod receptors |
| US5658783A (en) * | 1993-11-08 | 1997-08-19 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization | Mammalian methadone-specific opioid receptor gene and uses |
| US5476933A (en) * | 1994-11-16 | 1995-12-19 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon | Azepine synthesis via a diels-alder reaction |
| US5821219A (en) | 1995-08-11 | 1998-10-13 | Oregon Health Sciences University | Opioid antagonists and methods of their use |
| EP0845034B1 (en) | 1995-08-15 | 2003-03-05 | Euroscreen S.A. | peptide having pronociceptive properties |
-
1997
- 1997-05-27 CA CA002206192A patent/CA2206192A1/en not_active Abandoned
- 1997-06-03 US US08/868,355 patent/US6326156B1/en not_active Expired - Fee Related
- 1997-06-06 NZ NZ328033A patent/NZ328033A/en unknown
- 1997-06-06 IL IL12101797A patent/IL121017A0/xx unknown
- 1997-06-09 TR TR97/00482A patent/TR199700482A2/xx unknown
- 1997-06-09 ZA ZA9705077A patent/ZA975077B/xx unknown
- 1997-06-09 JP JP15117397A patent/JP3212537B2/ja not_active Expired - Fee Related
- 1997-06-11 HU HU9701032A patent/HUP9701032A3/hu unknown
- 1997-06-11 AR ARP970102532A patent/AR007548A1/es unknown
- 1997-06-11 CZ CZ971795A patent/CZ179597A3/cs unknown
- 1997-06-12 MX MX9704352A patent/MX9704352A/es unknown
- 1997-06-12 NO NO972707A patent/NO972707L/no not_active Application Discontinuation
- 1997-06-12 AU AU24853/97A patent/AU719519B2/en not_active Ceased
- 1997-06-12 PL PL97320527A patent/PL320527A1/xx unknown
- 1997-06-12 CN CN97113212A patent/CN1184254A/zh active Pending
- 1997-06-12 KR KR1019970024220A patent/KR100247670B1/ko not_active IP Right Cessation
- 1997-06-13 BR BR9703546A patent/BR9703546A/pt active Search and Examination
-
2001
- 2001-08-14 US US09/929,986 patent/US20020082213A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX9704352A (es) | 1997-12-31 |
| NO972707D0 (no) | 1997-06-12 |
| HU9701032D0 (en) | 1997-07-28 |
| AU2485397A (en) | 1997-12-18 |
| NO972707L (no) | 1997-12-15 |
| KR980003586A (ko) | 1998-03-30 |
| CA2206192A1 (en) | 1997-12-13 |
| ZA975077B (en) | 1997-12-15 |
| TR199700482A2 (xx) | 1998-01-21 |
| JP3212537B2 (ja) | 2001-09-25 |
| AU719519B2 (en) | 2000-05-11 |
| JPH1068724A (ja) | 1998-03-10 |
| CZ179597A3 (cs) | 1998-03-18 |
| AR007548A1 (es) | 1999-11-10 |
| US6326156B1 (en) | 2001-12-04 |
| NZ328033A (en) | 1998-11-25 |
| BR9703546A (pt) | 1998-09-29 |
| HUP9701032A3 (en) | 2000-04-28 |
| US20020082213A1 (en) | 2002-06-27 |
| HUP9701032A2 (hu) | 1998-08-28 |
| PL320527A1 (en) | 1997-12-22 |
| CN1184254A (zh) | 1998-06-10 |
| KR100247670B1 (ko) | 2000-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0871477A4 (en) | METHOD FOR OBTAINING ANTAGONIST ANTIBODIES OF RECEPTORS | |
| HUP9700559A2 (en) | Method for analysing condition of machines | |
| GB9608947D0 (en) | Method for determining parameters of hydrocarbon | |
| PL336998A1 (en) | Method of improving quality of hydrocarbons | |
| IL121017A0 (en) | Method of screening compounds for LC132 receptor agonist | |
| EP0846265A4 (en) | METHODS FOR THE PRELIMINARY ASSESSMENT OF THE ACTIVITY OF G PROTEIN COUPLED RECEPTORS | |
| EP1023434A4 (en) | METHOD FOR SCREENING ANTIMICROBIAL COMPOUNDS | |
| PL332482A1 (en) | Intermediate compounds for and method of obtaining olanzaoine | |
| EP0694078A4 (en) | SORTING PROCESS RELATING TO RECEPTOR AGONISTS | |
| AU6263996A (en) | Method for screening for receptor agonists and antagonists | |
| HU9702039D0 (en) | Estrogen agonist/antagonists treatment of atheroscerosis | |
| EP0873142A4 (en) | CONNECTION TESTING TESTS | |
| PL330708A1 (en) | Derivatives of indolydine useful as antagonists of 5-ht-2c receptor | |
| NZ322838A (en) | Method for determining feed quality | |
| GB9701245D0 (en) | Method of screening compounds | |
| GB9826890D0 (en) | Method for screening compounds | |
| EP1137938A4 (en) | METHODS FOR DETECTION OF HDPXU17 RECEPTOR AGONISTS AND ANTAGONISTS | |
| IL141810A0 (en) | Method for the rapid screening of analytes | |
| EP0912896A4 (en) | IDENTIFICATION OF ULTRASPIRACLE INHIBITORS | |
| EP0786084A4 (en) | METHOD FOR COMPOSITION SELECTION TESTS | |
| GB0106576D0 (en) | Method of screening for large offspring syndrome | |
| GB9908676D0 (en) | Method for screening compounds | |
| AU1177899A (en) | Screening for analytes using labeled receptors | |
| IL144726A0 (en) | Method for screening compound having affinity for vitamin d receptor | |
| FI102735B1 (fi) | Sahahakkeiden seulontalaitteisto |